What does REDE Consulting do?

REDE Consulting is a specialist ServiceNow IRM/GRC consultancy offering Strategic Advisory, Implementation, Development, and Managed Services exclusively for Finance, Pharma, and Healthcare.

Which industries does REDE Consulting serve?

REDE serves Financial Services (banking, insurance, fintech), Pharma & Life Sciences, and Healthcare exclusively, with deep regulatory expertise in DORA, HIPAA, GxP, FDA 21 CFR Part 11, and SOX.

When was REDE Consulting founded and where is it based?

REDE Consulting was founded in 2021 and is headquartered in Pune, Maharashtra, India, with operations across the USA, EU, DACH, Nordic, and Southeast Asia.

Third-Party and Supply Chain Risk: Closing the Gaps in Pharma's Extended Compliance Network

12 minutes ago
3 min read

The pharmaceutical industry is under constant scrutiny, not just for the efficacy and safety of its products, but also for the compliance of its extended supply chains. As regulatory requirements evolve, so too does the complexity of managing third-party risks. In this landscape, organizations must adapt their strategies to ensure robust compliance across all facets of their operations. One company leading the charge in this transformation is REDE, which is redesigning legacy systems into modern, AI-enabled solutions using ServiceNow.

The Importance of Addressing Third-Party Risks in Pharma

Pharma companies rely heavily on a network of third-party suppliers, manufacturers, and distributors. While these partnerships can enhance operational efficiency, they also introduce significant risks, including:

Regulatory Compliance: Non-compliance by a third party can lead to severe penalties and damage to the brand.
Quality Control: Inconsistent quality from suppliers can jeopardize product safety and efficacy.
Data Security: Third-party vendors often handle sensitive data, making them potential targets for cyberattacks.
Supply Chain Disruptions: Natural disasters, geopolitical issues, or financial instability can affect supply chain continuity.

To mitigate these risks, it is essential for pharma companies to have a comprehensive and proactive approach to compliance that encompasses the entire supply chain.

REDE's Role in Redesigning Legacy Systems

REDE is at the forefront of transforming the way pharmaceutical companies manage their compliance networks. By leveraging modern technologies, particularly AI and ServiceNow, REDE is helping organizations to close the gaps in their extended compliance networks. Here’s how:

1. Modernization of Legacy Systems

Many pharmaceutical companies still operate on outdated systems that are not equipped to handle the complexities of today’s compliance landscape. REDE assists in the modernization of these legacy systems, enabling companies to integrate new technologies that improve efficiency and compliance.

2. Implementation of AI-Enabled Solutions

Artificial Intelligence plays a crucial role in enhancing compliance monitoring and risk management. REDE’s AI-enabled solutions help pharma companies to:

Predict Risks: AI algorithms analyze vast amounts of data to identify potential compliance risks before they escalate.
Automate Processes: Automation reduces human error and speeds up compliance workflows, ensuring timely responses to regulatory changes.
Enhance Decision-Making: AI-driven insights provide leaders with the information needed to make informed decisions regarding third-party partnerships.

3. Streamlining Compliance with ServiceNow

ServiceNow is a powerful platform that facilitates the integration of various compliance processes into a single, cohesive system. REDE utilizes ServiceNow to:

Centralize Data: All compliance-related information is stored in one place, making it easier to access and manage.
Improve Collaboration: Teams can work together more effectively, sharing insights and updates in real-time.
Enhance Reporting: Automated reporting tools simplify the process of generating compliance reports for stakeholders and regulators.

Conclusion

As the pharmaceutical industry continues to evolve, the need for effective management of third-party and supply chain risks becomes increasingly critical. REDE's innovative approach to redesigning legacy systems with modern, AI-enabled solutions using ServiceNow is paving the way for a more compliant and resilient pharmaceutical landscape. By addressing the gaps in the extended compliance network, pharma companies can not only safeguard their operations but also enhance their reputation and trust with consumers. Embracing these advancements is not just an option; it is a necessity for the future of the industry.

About REDE Consulting

REDE Consulting is a specialized Integrated Risk Management (IRM) and Governance, Risk & Compliance (GRC) advisory firm built for pharmaceutical and life sciences organizations. We help pharma companies translate complex, fast-changing regulatory requirements into practical, auditable programs, reducing compliance exposure while freeing internal teams to focus on bringing safe, effective therapies to patients faster. Our team works alongside quality, regulatory, IT, and executive leadership to design governance frameworks that hold up under real-world inspection pressure.

Get in Touch

If your organization is looking to strengthen its IRM/GRC program, REDE Consulting can help you assess your current maturity, close critical gaps, and build a framework that scales as your business grows.

Reach out to our team at evita@rede-consulting.com to schedule a consultation and learn how REDE Consulting can support your pharmaceutical risk and compliance strategy.